Tick‑borne Disease, Antibody Panel
Use
This panel is intended to support the serologic diagnosis of multiple tick‑borne infections—including Lyme disease, Babesia microti and Babesia duncani, Anaplasma phagocytophilum, and Ehrlichia chaffeensis—by detecting IgG and IgM antibodies in specimens collected days to months or years after disease onset. It facilitates efficient differential diagnosis in regions with tick‑borne disease overlap.
Special Instructions
Not provided.
Limitations
IgM antibodies may persist longer than expected, potentially complicating interpretation. The CDC does not recommend IgM testing beyond 30 days of symptom onset for Lyme disease. Results reflect serologic response and may not indicate acute infection, especially in early disease.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
Not provided
Container
serum separator tube (SST) transferred to plastic transport tube
Other tests from different labs that may be relevant